Company / Operating Cash Flow per Share
KIORA PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.32
FY2025
5-year range
-$11.16 / $0.32
FY2021-FY2025
Trend
+102.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-11.16 in FY2024 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025.
Improved from $-1.32 to $0.32 over the past 4 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 102.9% year-over-year.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | +102.9% |
| FY2024 | -$11.16 | -747.6% |
| FY2021 | -$1.32 | +34.1% |
| FY2020 | -$2.00 | +44.0% |
| FY2019 | -$3.57 | -852.1% |
| FY2018 | -$0.37 | +54.9% |
| FY2017 | -$0.83 | -42.6% |
| FY2016 | -$0.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026